Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
This study highlights the high incidence of HE following TIPS and shows that DM is a significant and independent risk factor for the development of HE. Given the increase in patients with metabolic dysfunction-associated liver cirrhosis and DM, this study offers additional insights into the balance of risks and benefits associated with TIPS placement.
Authors
- Dave Sprengers (ORCID: https://orcid.org/0000-0003-4280-4210)
- Robert J. de Knegt (ORCID: https://orcid.org/0000-0003-0934-6975)
- Raoel Maan (ORCID: https://orcid.org/0000-0001-6402-398X)
- Nicole S. Erler (ORCID: https://orcid.org/0000-0002-9370-6832)
- Sarwa Darwish Murad (ORCID: https://orcid.org/0000-0003-2804-1165)
- Caroline M. den Hoed (ORCID: https://orcid.org/0000-0003-3840-0213)
- Milan J. Sonneveld (ORCID: https://orcid.org/0000-0002-9253-563X)
- Michelle Spaan (ORCID: https://orcid.org/0000-0002-6692-1553)
- Diederik C. Bijdevaate
- Willem Pieter Brouwer (ORCID: https://orcid.org/0000-0001-8713-1481)
- Anne Van Eldere
- Kay Pieterman
- Willemijn Dijkstra
- Sandra Coenen
- Ellen Werner
- Harry L.A. Janssen
- Rozanne C. de Veer (ORCID: https://orcid.org/0000-0003-1604-0931)
Institutions
- Toronto General Hospital (CA)
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- Erasmus MC Transplant Institute
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1111/apt.70453
- Citations
- 4
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 5.29